Showing promise in the arena of weight management treatment, retatrutide is a unique method. Unlike many existing medications, retatrutide operates as a double agonist, concurrently targeting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic polypeptide (GIP) sensors. The dual activation encourages several advantageous effects,